Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

110.17
BATS BZX Real-Time Price
As of 12:56pm ET
 -0.16 / -0.15%
Today’s Change
81.12
Today|||52-Week Range
121.75
+17.58%
Year-to-Date
Medtronic Advances in Pain Therapy With U.S. Intellis Launch
10:19am / Zacks.com - Paid Partner Content
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
Sep 21 / Zacks.com - Paid Partner Content
Here's Why You Should Add Abbott (ABT) to Your Portfolio Now
10:08am / Zacks.com - Paid Partner Content
Why is Edwards Lifesciences (EW) a Strong Buy Stock Now?
Sep 21 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Masimo (MASI) Right Now
9:19am / Zacks.com - Paid Partner Content
Here's Why You Should Add Chemed (CHE) to Your Portfolio
Sep 21 / Zacks.com - Paid Partner Content
Amedisys or Chemed: Which is a Better Investment Choice?
9:07am / Zacks.com - Paid Partner Content
Here's Why You Should Bet on BioTelemetry (BEAT) Stock Now
Sep 21 / Zacks.com - Paid Partner Content
Why Should Investors Add Amedisys (AMED) to Their Portfolio?
Sep 21 / Zacks.com - Paid Partner Content
BD (BDX) Inks New Deal to Strengthen Foothold in STI Space
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close110.33
Today’s open110.28
Day’s range109.23 - 110.33
Volume54,033
Average volume (3 months)1,226,940
Market cap$23.3B
Dividend yield--
Data as of 12:56pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+16.00%
Earnings growth (this year)+30.83%
Earnings growth (next 5 years)+16.67%
Revenue growth (last year)+18.85%
P/E ratio33.3
Price/Sales6.89
Price/Book8.91

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.03+0.08%
ISRGIntuitive Surgical-3.74-0.36%
STESTERIS plc+0.31+0.36%
HRCHill-Rom Holdings In...+0.17+0.23%
Data as of 12:56pm ET, 09/22/2017

Financials

Next reporting dateOctober 30, 2017
EPS forecast (this quarter)$0.86
Annual revenue (last year)$3.0B
Annual profit (last year)$569.5M
Net profit margin19.22%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts